In a recent attempt to obtain a better detection tool, serum levels of HE4 and CA125 were incorporated with menopausal status leading to the development of ROMA (risk of ovarian malignancy algorithm) in detecting ovarian cancer from benign pelvic masses even in early stages. The gene discussed is WFDC2; the disease is ovarian carcinoma.